More Evidence On Benefits Of High Blood Pressure Drugs In Diabetic Eye Disease
/* 468x60, */
Scientists in Massachusetts are reporting new evidence that certain high blood pressure drugs may be useful in preventing and treating diabetic retinopathy, the leading cause of vision loss in people with diabetes. The study, the largest to date on proteins in the retina, could lead to new ways to prevent or treat the sight-threatening disease, they say. The findings are in ACS' Journal of Proteome Research, a monthly publication.
Edward Feener and colleagues point out that diabetic retinopathy is a common complication of diabetes, which affects millions of people worldwide. It involves damage to blood vessels in the retina, the light sensitive tissue in the back of the eye. Previous studies suggested that drugs used to treat high blood pressure, including ACE inhibitors and angiotensin receptor blockers (ARBs), may help prevent the condition.
The scientists analyzed proteins from the retinas laboratory mice with normal blood pressure and diabetes and compared them to those of non-diabetic mice. They identified 65 abnormal proteins in the diabetic mice out of more than 1,700 proteins in the study. Treatment with the ARB medication, candesartan, prevented the abnormal changes in more than 70 percent of the proteins.
Article: "Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes" http://pubs.acs.org/doi/full/10.1021/pr9006415
Source: Michael Bernstein
American Chemical Society
/* 468x60, */
Last relative articles:
- NICE Appraisal Of Liraglutide For Type 2 Diabetes
- Insulin Regulates Beta Cell Function In Healthy Humans
- NHS Diabetes Care Continues To Improve, UK
- Role Of Protein Pair In Obesity Regulation Highlighted By Research
- International Diabetes Federation Awards US 2 Million To 9 Global Diabetes Research Projects
- Biodel To Present Results From VIAject R Phase 3 Studies At Advanced Technologies And Treatments For Diabetes Conference In Basel
- Eye Damage From Diabetes Remains The Leading Cause Of Blindness In Adults; 5.3 Million In U.S. Suffer From Diabetic Retinopathy
- Is 2 Years Old A Childhood Obesity Tipping Point?
- Doctors Urged To Manage Cardiovascular Risk Factors Of Migraine Sufferers
- GI Dynamics' EndoBarrier trade; Gastrointestinal Liner To Be Highlighted At Upcoming Cleveland Clinic Conference
blood, blood pressure, benefits blood, blood vessels, evidence blood, damage blood, normal blood, treat blood